🔬 Hong Kongs Biotech Edge Unveiled Through BIOHK
Published by OOPSONLINE.IN · Source: The Manila Times · 1 min read · · Updated
What actually happened
HONG KONG, Aug. 10, 2026 /PRNewswire/ -- Per BIOHK2025 official briefing materials, a Swiss cell therapy biotech founder scans the bustling conference floor of BIOHK2025, shaking hands with Nobel laureates, Hong Kong financial regulators, mainland biotech lab directors and Asia-focused venture capitalists all within a single day. For decades, his firm chased dual goals: breaking into China's vast clinical and consumer market while retaining seamless access to Western regulatory standards, cross-border capital and global research talent. In Hong Kong, he found a rare middle ground no other Asia
Key points
- 10, 2026 /PRNewswire/ -- Per BIOHK2025 official briefing materials, a Swiss cell therapy biotech founder scans the bustling conference floor of BIOHK2025, shaking hands with Nobel laureates, Hong Kong financial regulators, mainland biotech lab directors and Asia-focused venture capitalists all within a single day.
- For decades, his firm chased dual goals: breaking into China's vast clinical and consumer market while retaining seamless access to Western regulatory standards, cross-border capital and global research talent.
- In Hong Kong, he found a rare middle ground no other Asia
Summary based on data provided by The Manila Times. Full article available at the original publisher.
- #science
- #hong
- #kong